Founded in 2004, Pharmaron is a cutting-edge, fully integrated pharmaceutical R&D service platform supporting the life science industry. The company has invested in its people and facilities and established its comprehensive service offerings throughout the pharmaceutical R&D lifecycle. With operations in China, the US and the UK staffed by more than 11,000 employees, Pharmaron has an excellent track record in delivering end-to-end R&D solutions to its partners globally and enabling them to accelerate their novel drug discovery and development process.
Pharmaron is a contract research organization (CRO).
* Synthetic, medicinal and analytical chemistry services
* Biology services
* DMPK services
* Pharmacology services
* Drug safety assessment services
* Radiochemistry and isotopically labelled metabolism services
* Chemical & pharmaceutical development services
* Clinical development services
CRO - Contract Research Organization
Discovery Process Chemistry
Radiolabelled Chemical Synthesis
in vitro Biology
in vitro Screening
in vivo Pharmacology
Animal Disease Models
ex vivo Pharmacology
in vitro ADME
in vivo PK
Drug Product Manufacturing
14C / Carbon-14 Radiosynthesis
3H / Tritium Radiosynthesis
Microdosing Phase 0
Site-directed mutagenesis (SDM)
is an invaluable technique for studying protein and gene function in molecular biology and in protein engineering fields.
Mutagenex provides comprehensive services for in vitro site-directed mutagenesis and gene manipulation to facilitate our customers' research. Based on innovative gene synthesis and PCR technology, we offer all services at reasonable prices with minimum turnaround time.
Toxikon Corporation is a preclinical Contract Research Organization (CRO), with ISO/IEC 17025 accreditation that is registered with the US FDA and Japanese MHLW for drug and medical device testing. The Company provides in vivo, analytical, and in vitro testing services for the medical device, pharmaceutical and biotechnology sectors. Toxikon’s services include biocompatibility, surgical and ocular models, extractable & leachable (E&L), risk assessments, microbiology (cleaning, disinfection and sterilization validations), toxicology (including toxicity, genetic toxicology and carcinogenicity), PK, TK, ADME, chemical characterization, impurities analysis and synthesis and bioanalytical.
Toxikon was founded in 1982 and is headquartered in Bedford, MA. Toxikon’s laboratory facilities are fully accredited including GLP/GMP registrations, and the Bedford facilities have full USDA, OLAW, and AAALAC animal testing credentials. In addition, both facilities are ISO accredited, enabling GLP and non-GLP work across both facilities. The Company currently has approximately 80 animal rooms, and has extensive and fully equipped surgical suites, along with support services that include efficacy and research services, and histology and clinical pathology. The Company currently serves over 1,000 active customers across the medical device pharmaceutical, biotechnology sectors through-out the world.
Alta Biotech is a fast-growing global contract research organization specializing in molecular biology, biochemistry and cell biology services. Our core area of expertise includes plasmid DNA purification, gDNA and total RNA extraction, gene synthesis and a wide portfolio of customized fundamental life science research support services. With facilities located in the heart of the Fitzsimons Life Science District in Colorado, Alta Biotech has developed a variety of in-house technology platforms to provide fast, high-quality, and cost-effective services to exceed customer expectations. Our goal is to serve as a trusted bioscience partner to our customers.
Altogen Labs is a biology CRO company providing GLP preclinical research services, tox studies for IND applications, RNAi and gene silencing services, xenograft testing services (100+ tumorigenic cell lines), in vivo siRNA delivery and biodistribution, development of stable cell lines, and many more.
Altogen Labs is a GLP compliant laboratory that provides preclinical research and biotechnology contract research services (CRO) to pharma, biotechnology companies, universities, and cancer research centers worldwide. Our services include pharmacology and toxicology assays (IC50), cell banking, generation of stable cell lines, RNAi gene silencing and other in vitro services. Altogen Labs provides following in vivo services for efficacy studies in the drug discovery phase: rodent xenograft models, teratoma formation and analysis services, cancer disease animal models, in vivo siRNA delivery and tissue targeting, pharmacokinetics (PK) and pharmacodynamics (PD) services, immune response and biomarker analysis.
Altogen Labs recently developed an `active bioremediation` process based on an approach using the most potent oil-degrading bacteria found at multiple oil spill sites in Texas. This technology allows remediation of large amounts of hydrocarbon-contaminated liquids or soil. The genomes of both microorganisms were recently sequenced, which revealed that both strains were previously unreported in the literature. Altogen Labs filed bioremeddiation patent application in 6/2012.